Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in gene therapy for cardiac disease.

S K Wattanapitayakul1, J A Bauer

  • 1Department of Pharmacology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|December 29, 2000
PubMed
Summary

Cardiac gene therapy offers new strategies for cardiovascular disease, but requires optimized vectors and delivery methods. Long-term effectiveness needs further research for successful clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Timing of umbilical cord clamping among infants born at 22 through 27 weeks' gestation.

Journal of perinatology : official journal of the California Perinatal Association·2015
Same author

Early versus delayed umbilical cord clamping in infants with congenital heart disease: a pilot, randomized, controlled trial.

Journal of perinatology : official journal of the California Perinatal Association·2015
Same author

Pummelo protects Doxorubicin-induced cardiac cell death by reducing oxidative stress, modifying glutathione transferase expression, and preventing cellular senescence.

Evidence-based complementary and alternative medicine : eCAM·2013
Same author

Pediatric trends.

Southern medical journal·2010
Same author

Effects of hyperoxia on postnatal intestinal development.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2007
Same author

Innervation and connexin isoform expression during diabetes-related bladder dysfunction: early structural vs. neuronal remodelling.

Acta diabetologica·2005

Area of Science:

  • Molecular biology
  • Genetics
  • Cardiology

Background:

  • Cardiovascular disease is a leading global cause of mortality.
  • Advances in molecular biology and genomics present opportunities for cardiac gene therapy.
  • Gene transfer strategies are being explored to address cardiac disease.

Purpose of the Study:

  • To review general and specific aspects of gene transfer strategies for cardiac tissues.
  • To discuss key considerations for effective cardiac gene therapy.

Main Methods:

  • Review of current vectors (viral and nonviral) and identified target genes (e.g., VEGF, FGF, beta-AR).
  • Analysis of experimental models for gene delivery systems.
  • Evaluation of administration methods, including intramyocardial injection and perfusion of explanted myocardium.

Related Experiment Videos

Main Results:

  • Several vectors and target genes have been identified for cardiac gene therapy.
  • Intramyocardial injection and perfusion of explanted myocardium show efficient gene transfer.
  • Immediate positive effects of gene transfer have been observed in experimental models.

Conclusions:

  • Cardiac gene therapy holds promise but requires further refinement of vectors for selectivity and long-lasting effects.
  • Development of minimally invasive gene transfer procedures is essential for clinical translation.
  • Long-term efficacy of cardiac gene therapy remains to be proven.